Cerebrovascular complications of Fabry's disease

被引:228
作者
Mitsias, P
Levine, SR
机构
[1] Center for Stroke Research, Department of Neurology, Henry Ford Hosp. and Hlth. Sci. Ctr., Detroit, MI
[2] Center for Stroke Research, Department of Neurology (K-11), Henry Ford Hosp. and Hlth. Sci. Ctr., Detroit, MI 48202-2689
关键词
D O I
10.1002/ana.410400105
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Fabry's disease (FD) is a rare, sex-linked disorder resulting from alpha-galactosidase deficiency. Cerebrovascular complications have been reported in the literature but have not been systematically analyzed, We report 2 patients and review 51 previously reported cases (descriptive meta-analysis) to clarify the clinical, radiologic, and pathologic features, The average age at onset of cerebrovascular symptoms was 33.8 years for hemizygous individuals (n = 43) and 40.3 years of heterozygotes (n = 10). The most frequent symptoms and signs were as follows (in descending order of frequency): hemiparesis, vertigo/dizziness, diplopia, dysarthria, nystagmus, nausea/vomiting, head pain, hemiataxia, and ataxia of gait, in the hemizygote group; and memory loss, dizziness, ataxia, hemiparesis, loss of consciousness and hemisensory symptoms, in the heterozygote group, The vertebrobasilar circulation was symptomatic in 67% of the hemizygotes and 60% of the heterozygotes. Intracerebral hemorrhage was found in 4 patients (3 hemizygotes and 1 heterozygote). Elongated, ectatic, tortuous vertebral and basilar arteries were the most common angiographic and pathologic features. For the hemizygotes, the recurrence rate for cerebrovascular disease was 76% and the death rate was 55%; 86% of the heterozygotes had recurrent cerebrovascular event(s) and 40% died. The cerebrovascular manifestations of FD, in both hemizygotes and heterozygotes, are predominantly due to dilative arteriopathy of the vertebrobasilar circulation, frequently recur, and portend a poor prognosis.
引用
收藏
页码:8 / 17
页数:10
相关论文
共 83 条
[1]  
Archer BWC, 1927, LANCET, V2, P595
[2]   PLATELET ACTIVITY IN MITRAL-VALVE PROLAPSE - A STUDY OF PLATELET-AGGREGATION, MALONDIALDEHYDE PRODUCTION, AND PLASMA BETA-THROMBOGLOBULIN [J].
AROCHA, F ;
DIEZEWALD, M ;
DURANGO, AI ;
SULBARAN, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1985, 19 (01) :21-25
[3]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[4]   FURTHER EVIDENCE RELATING MITRAL-VALVE PROLAPSE TO CEREBRAL ISCHEMIC EVENTS [J].
BARNETT, HJM ;
BOUGHNER, DR ;
TAYLOR, DW ;
COOPER, PE ;
KOSTUK, WJ ;
NICHOL, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (03) :139-144
[5]   ANGIOKERATOMA CORPORIS DIFFUSUM [J].
BASS, BH .
BRITISH MEDICAL JOURNAL, 1958, 1 (JUN14) :1418-1418
[6]   CARDIAC MANIFESTATIONS OF FABRYS-DISEASE - REPORT OF A CASE WITH MITRAL-INSUFFICIENCY AND ELECTROCARDIOGRAPHIC EVIDENCE OF MYOCARDIAL-INFARCTION [J].
BECKER, AE ;
SCHOORL, R ;
BALK, AG ;
VANDERHEIDE, RM .
AMERICAN JOURNAL OF CARDIOLOGY, 1975, 36 (06) :829-835
[7]   ANGIOKERATOMA CORPORIS DIFFUSUM UNIVERSALE (FABRYS DISEASE) IN 2 BROTHERS [J].
BETHUNE, JE ;
LANDRIGAN, PL ;
CHIPMAN, CD .
NEW ENGLAND JOURNAL OF MEDICINE, 1961, 264 (25) :1280-&
[8]   NEUROLOGICAL MANIFESTATIONS OF FABRY DISEASE IN FEMALE CARRIERS [J].
BIRD, TD ;
LAGUNOFF, D .
ANNALS OF NEUROLOGY, 1978, 4 (06) :537-540
[9]   THE MEGADOLICHOBASILAR ANOMALY [J].
BOERI, R ;
PASSERINI, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1964, 1 (05) :475-484
[10]   THE LAUSANNE STROKE REGISTRY - ANALYSIS OF 1,000 CONSECUTIVE PATIENTS WITH 1ST STROKE [J].
BOGOUSSLAVSKY, J ;
VANMELLE, G ;
REGLI, F .
STROKE, 1988, 19 (09) :1083-1092